The Leukemia evaluation employs cell surface & cytoplasmic markers as a two step process to aid in the diagnosis and characterisation of neoplasms of hematopoietic origin. Results are useful in the differential diagnosis, therapeutic monitoring and detection of relapses of these neoplasms.